Kiniksa Pharmaceuticals International Plc (KNSA)
42.67
+0.94
(+2.25%)
USD |
NASDAQ |
Jan 09, 16:00
42.60
-0.07
(-0.16%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International Total Assets (Quarterly): 712.33M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | 21.73M |
| ADMA Biologics, Inc. | 568.69M |
| NovoCure Ltd. | 1.361B |
| LivaNova Plc | 2.558B |
| Akanda Corp. | -- |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 176.95M |
| Shareholders Equity (Quarterly) | 535.38M |
| Debt to Equity Ratio | 0.0182 |
| Current Ratio | 3.848 |
| Net Debt Paydown Yield | 0.01% |